These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A Prediction Model to Identify Febrile Infants ≤60 Days at Low Risk of Invasive Bacterial Infection. Aronson PL; Shabanova V; Shapiro ED; Wang ME; Nigrovic LE; Pruitt CM; DePorre AG; Leazer RC; Desai S; Sartori LF; Marble RD; Rooholamini SN; McCulloh RJ; Woll C; Balamuth F; Alpern ER; Shah SS; Williams DJ; Browning WL; Shah N; Neuman MI; Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31167938 [TBL] [Abstract][Full Text] [Related]
6. Is a lumbar puncture necessary when evaluating febrile infants (30 to 90 days of age) with an abnormal urinalysis? Paquette K; Cheng MP; McGillivray D; Lam C; Quach C Pediatr Emerg Care; 2011 Nov; 27(11):1057-61. PubMed ID: 22068068 [TBL] [Abstract][Full Text] [Related]
7. Accuracy of PECARN rule for predicting serious bacterial infection in infants with fever without a source. Velasco R; Gomez B; Benito J; Mintegi S Arch Dis Child; 2021 Feb; 106(2):143-148. PubMed ID: 32816694 [TBL] [Abstract][Full Text] [Related]
8. Application of the Rochester Criteria to Identify Febrile Infants With Bacteremia and Meningitis. Aronson PL; McCulloh RJ; Tieder JS; Nigrovic LE; Leazer RC; Alpern ER; Feldman EA; Balamuth F; Browning WL; Neuman MI; Pediatr Emerg Care; 2019 Jan; 35(1):22-27. PubMed ID: 29406479 [TBL] [Abstract][Full Text] [Related]
9. Risk-stratification in febrile infants 29 to 60 days old: a cost-effectiveness analysis. Noorbakhsh KA; Ramgopal S; Rixe NS; Dunnick J; Smith KJ BMC Pediatr; 2022 Feb; 22(1):79. PubMed ID: 35114972 [TBL] [Abstract][Full Text] [Related]
13. Association of RNA Biosignatures With Bacterial Infections in Febrile Infants Aged 60 Days or Younger. Mahajan P; Kuppermann N; Mejias A; Suarez N; Chaussabel D; Casper TC; Smith B; Alpern ER; Anders J; Atabaki SM; Bennett JE; Blumberg S; Bonsu B; Borgialli D; Brayer A; Browne L; Cohen DM; Crain EF; Cruz AT; Dayan PS; Gattu R; Greenberg R; Hoyle JD; Jaffe DM; Levine DA; Lillis K; Linakis JG; Muenzer J; Nigrovic LE; Powell EC; Rogers AJ; Roosevelt G; Ruddy RM; Saunders M; Tunik MG; Tzimenatos L; Vitale M; Dean JM; Ramilo O; JAMA; 2016 Aug 23-30; 316(8):846-57. PubMed ID: 27552618 [TBL] [Abstract][Full Text] [Related]
14. Costs and infant outcomes after implementation of a care process model for febrile infants. Byington CL; Reynolds CC; Korgenski K; Sheng X; Valentine KJ; Nelson RE; Daly JA; Osguthorpe RJ; James B; Savitz L; Pavia AT; Clark EB Pediatrics; 2012 Jul; 130(1):e16-24. PubMed ID: 22732178 [TBL] [Abstract][Full Text] [Related]
16. Value of serum C-reactive protein concentrations in febrile children without apparent focus. Kohli V; Singhi S; Sharma P; Ganguly NK Ann Trop Paediatr; 1993; 13(4):373-8. PubMed ID: 7506886 [TBL] [Abstract][Full Text] [Related]
17. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Levine DA; Platt SL; Dayan PS; Macias CG; Zorc JJ; Krief W; Schor J; Bank D; Fefferman N; Shaw KN; Kuppermann N; Pediatrics; 2004 Jun; 113(6):1728-34. PubMed ID: 15173498 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for urinary tract infections in children aged 0-36months presenting with fever without source and evaluated for risk of serious bacterial infections. Williams-Smith JA; Fougère Y; Pauchard JY; Asner S; Gehri M; Crisinel PA Arch Pediatr; 2020 Oct; 27(7):372-379. PubMed ID: 32919843 [TBL] [Abstract][Full Text] [Related]
19. Management of fever without source in infants and children. Baraff LJ Ann Emerg Med; 2000 Dec; 36(6):602-14. PubMed ID: 11097701 [TBL] [Abstract][Full Text] [Related]